{
    "table_name": "HTAN_VERSIONED.CLINICAL_TIER3_BRAIN_R4",
    "table_fullname": "HTAN_1.HTAN_VERSIONED.CLINICAL_TIER3_BRAIN_R4",
    "column_names": [
        "HTAN_CENTER",
        "TIMEPOINT_LABEL",
        "GLIOMA_SPECIFIC_RADIATION_FIELD",
        "MANIFEST_ID",
        "HTAN_PARTICIPANT_ID",
        "NEUROBLASTOMA_MYCN_GENE_AMPLIFICATION_STATUS",
        "MANIFEST_VERSION",
        "ENTITYID",
        "COMPONENT",
        "SUPRA_TENTORIAL_EPENDYMOMA_MOLECULAR_SUBGROUP",
        "GLIOMA_SPECIFIC_METASTASIS_SITES",
        "INFRA_TENTORIAL_EPENDYMOMA_MOLECULAR_SUBGROUP",
        "CNS_TUMOR_PRIMARY_ANATOMIC_SITE",
        "ID",
        "STOP_DAYS_FROM_INDEX",
        "START_DAYS_FROM_INDEX"
    ],
    "column_types": [
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "NUMBER",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT"
    ],
    "description": [
        "Name of HTAN Center e.g. HTAN HTAPP",
        "Label to identify the time point at which the clinical data or biospecimen was obtained (e.g. Baseline, End of Treatment, Overall survival, Final). NO PHI/PII INFORMATION IS ALLOWED.",
        "A description of the location on or within the CNS where radiation was administered in a partcipant with glioma",
        "Synapse ID of manifest containing file annotation",
        "HTAN ID associated with a patient based on HTAN ID SOP (eg HTANx_yyy )",
        "Neuroblastoma MYCN amplification or over-expression status",
        "Latest version of metadata manifest",
        "Synapse ID of entity",
        "Category of metadata (e.g. Diagnosis, Biospecimen, scRNA-seq Level 1, etc.); provide the same one for all items/rows.",
        "Text term to identify the molecular subgroup in a supra tentorial ependymoma",
        "Evidence of active brain metastasis including leptomeningeal involvement",
        "Text term to identify the molecular subgroup in a infra tentorial ependymoma",
        "Primary tumor location in the central nervous system that comprise the tissues of the central nervous system (brain and spinal cord)-not covered in Tiers 1 and 2",
        "Unique identifier of entity e.g. a96059eb-81af-4b24-ae50-9242c0d8f819",
        "Number of days from the date of birth (index date) to the end date of the event (e.g. exposure to environmental factor, treatment start, etc.). Note: if the event occurs at a single time point, e.g. a diagnosis or a lab test, the values for this column is 'Not Applicable'",
        "Number of days from the date of birth (index date) to the date of an event (e.g. exposure to environmental factor, treatment start, etc.). If not applicable please enter 'Not Applicable'"
    ],
    "sample_rows": [
        {
            "ENTITYID": "syn25883903",
            "STOP_DAYS_FROM_INDEX": null,
            "HTAN_PARTICIPANT_ID": "HTA1_289",
            "CNS_TUMOR_PRIMARY_ANATOMIC_SITE": "Cerebellar/Posterior fossa",
            "GLIOMA_SPECIFIC_RADIATION_FIELD": null,
            "ID": "13cf19e0-8d5d-4cba-97d3-8215a608f4a0",
            "INFRA_TENTORIAL_EPENDYMOMA_MOLECULAR_SUBGROUP": null,
            "SUPRA_TENTORIAL_EPENDYMOMA_MOLECULAR_SUBGROUP": null,
            "GLIOMA_SPECIFIC_METASTASIS_SITES": null,
            "TIMEPOINT_LABEL": "Not Recorded",
            "COMPONENT": "NeuroblastomaandGliomaTier3",
            "START_DAYS_FROM_INDEX": "Not Applicable",
            "NEUROBLASTOMA_MYCN_GENE_AMPLIFICATION_STATUS": null,
            "HTAN_CENTER": "HTAN HTAPP",
            "MANIFEST_ID": "syn52234452",
            "MANIFEST_VERSION": 2
        }
    ]
}